Brain as a Therapeutic and Research Target in Trigeminal Neuropathic Pain

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Trigeminal Neuropathic Pain
Interventions
PROCEDURE

PET Scans

Two 90 minute scans whose maximum radiological dose is 15 mCi \[11 C\] carfentanil, a selective and specific mu-opioid receptor radioligand. The first one provided baseline data, and the second occurred with the sequence of sham tDCS and tDCS as described in each arm description.

PROCEDURE

transcranial direct current stimulation (tDCS)

In active tDCS, a 2 milli-amp transcranial direct current stimulation is for 20 minutes.

PROCEDURE

MRI

No radiotracer is used; 3 tesla scanner; all participants have MRI prior to PET scans.

OTHER

sham tDCS (prior to real tDCS)

For sham tDCS, current is applied only for 30 seconds, as sensations arising from tDCS treatment occur only at the beginning of application; however the equipment will be on the participant for 20 minutes to match that of the active tDCS application.

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER

NCT03003715 - Brain as a Therapeutic and Research Target in Trigeminal Neuropathic Pain | Biotech Hunter | Biotech Hunter